Close X
Friday, November 29, 2024
ADVT 
International

At 42, Rishi Sunak youngest person to take UK PM office in over 200 years

Darpan News Desk IANS, 24 Oct, 2022 09:41 AM
  • At 42, Rishi Sunak youngest person to take UK PM office in over 200 years

London, Oct 24 (IANS) Conservative party's Rishi Sunak will become the first Hindu and the first person of colour to become Britain's Prime Minister. At the age of 42, he is also the youngest person to take the office in more than 200 years.

The result of Monday's contest caps a spectacularly rapid rise to the pinnacle of British politics, CNN reported.

Sunak was first elected as an MP in 2015 and spent two years on the backbenches, during which Brexit dominated the political agenda. Sunak supported leaving the EU during the 2016 referendum.

He subsequently became a junior minister in former Prime Minister Theresa May's government.

It was another former Prime Minister Boris Johnson who gave Sunak his first major government role when he first appointed him as the Chief Secretary to the Treasury in 2019, and as the Chancellor in 2020.

Sunak won popularity during the early weeks of the pandemic when he unveiled an extensive support plan for those unable to work during lockdown.

But the "Partygate" scandal that took down Boris Johnson also tarnished his reputation, and he became archrivals with Johnson after quitting his government earlier this year. Congratulations poured in from Indian PM Narendra Modi.

Sunak has remained tight-lipped on his policy plan in the last few days but he was widely seen as the more moderate of the two candidates in the last leadership contest over the summer. Compared to Liz Truss, he took a softer line on matters like Brexit and the economy, CNN reported.

MORE International ARTICLES

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine